microdosing glp 1 perimenopause GLP-1 for Perimenopause: Why Lower Doses Might Be Better THE PCCA BLOG | Microdosing

As a result, the patients stomach does not emptyor fails to empty to the extent it shouldmeaning food stays in the stomach longer than it should, rather than moving on for digestion in the small intestine

Its dual GLP-1/glucagon action also improves liver fat metabolism, making it especially promising for patients with obesity and liver-related conditions like MASH

What exactly is microdosing

When administered in therapeutic doses, semaglutide helps reduce appetite, increase satiety after meals, and slow gastric emptyingmechanisms that collectively support consistent caloric control without extreme dietary restriction